The Australian Therapeutic Goods Administration (TGA) has granted medical software developer Densitas permission to sell its breast density software in the country.
The DM-Density algorithm can automatically determine patients' breast density category in a few seconds by reading their mammograms, according to the company. The automated software will be available through the EnvoyAI platform.
